Loading…
Tuesday October 1, 2024 2:30pm - 3:15pm EDT
  • Assess the risks and rewards of involving NPP in the early stages of R&D, including case studies that highlight the outcomes of various timing strategies.
  • Explore effective strategies for fostering strong relationships and thought partnerships between NPP and R&D teams to enhance collaborative efforts.
  • Delve into the development and implementation of stage-appropriate assessments and process "road maps" in a collaborative, cross-functional environment.
Speakers
avatar for Sonal Das

Sonal Das

Senior Director, Global Commercial, argenyx
avatar for Cathy Garabedian

Cathy Garabedian

Executive Director, New Product Planning, Keros Therapeutics
avatar for Kathleen Davenport

Kathleen Davenport

Vice President, Strategy, Omega Therapeutics
avatar for Mike Conlon

Mike Conlon

Consultant, BioMarin
avatar for Tony Russell

Tony Russell

Executive Director, Head of New Product Commercialization, BioMarin
Tuesday October 1, 2024 2:30pm - 3:15pm EDT
Log in to leave feedback.

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Share Modal

Share this link via

Or copy link